TECX vs TNYA

Tectonic Therapeutic, Inc. vs Tenaya Therapeutics, Inc. — Valuation Comparison 2026

TECX

Biological Products, (No Diagnostic Substances)
Tectonic Therapeutic, Inc.
Quality
4.3
out of 10
Value Trap
18
SAFE
Price
$31.16
Last close
Models
7/13
Active
VS

TNYA

Biological Products, (No Diagnostic Substances)
Tenaya Therapeutics, Inc.
Quality
4.1
out of 10
Value Trap
30
LOW
Price
$0.87
Last close
Models
8/13
Active

Model-by-Model Comparison

ModelType TECX Fair ValueTECX Upside TNYA Fair ValueTNYA Upside
Bayesian DCF Intrinsic $14.60 -53.2% $0.40 -54.5%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $18.11 -41.9% $0.79 -9.1%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for TECX vs TNYA — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

TECX vs TNYA — Which Stock Is More Undervalued?

TECX scores higher with a 4.3/10 quality rating vs TNYA's 4.1/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Tectonic Therapeutic, Inc. (TECX) and Tenaya Therapeutics, Inc. (TNYA) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

TECX currently trades at $31.16 with a QOC of 4.3/10, while TNYA trades at $0.87 with a QOC of 4.1/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).